List of Excipients in API neostigmine methylsulfate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing neostigmine methylsulfate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Exela Pharma Sciences LLC | BLOXIVERZ | neostigmine methylsulfate | 51754-1210 | ACETIC ACID | |
| Exela Pharma Sciences LLC | BLOXIVERZ | neostigmine methylsulfate | 51754-1210 | PHENOL | |
| Exela Pharma Sciences LLC | BLOXIVERZ | neostigmine methylsulfate | 51754-1210 | SODIUM ACETATE | |
| Exela Pharma Sciences LLC | BLOXIVERZ | neostigmine methylsulfate | 51754-1210 | SODIUM HYDROXIDE | |
| Exela Pharma Sciences LLC | BLOXIVERZ | neostigmine methylsulfate | 51754-1210 | WATER | |
| Exela Pharma Sciences LLC | BLOXIVERZ | neostigmine methylsulfate | 51754-1240 | ACETIC ACID | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing neostigmine methylsulfate
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Henry Schein Inc | neostigmine methylsulfate | 0404-9925 | ACETIC ACID |
| Henry Schein Inc | neostigmine methylsulfate | 0404-9925 | PHENOL |
| Henry Schein Inc | neostigmine methylsulfate | 0404-9925 | SODIUM ACETATE |
| Henry Schein Inc | neostigmine methylsulfate | 0404-9925 | SODIUM HYDROXIDE |
| Henry Schein Inc | neostigmine methylsulfate | 0404-9925 | WATER |
| American Regent Inc | neostigmine methylsulfate | 0517-1133 | ACETIC ACID |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for neostigmine methylsulfate
Excipient focus: ACETIC ACID
neostigmine methylsulfate drug variants containing ACETIC ACID
neostigmine methylsulfate drug variants not containing ACETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Indoco Remedies Limited | neostigmine methylsulfate | 14445-413 |
| PAR PHARMACEUTICAL INC | neostigmine methylsulfate and glycopyrrolate | 42023-269 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
neostigmine methylsulfate drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| PAR PHARMACEUTICAL INC | neostigmine methylsulfate and glycopyrrolate | 42023-269 |
| >Company | >Ingredient | >NDC |
neostigmine methylsulfate drug variants not containing EDETATE DISODIUM
Excipient focus: HYDROCHLORIC ACID
neostigmine methylsulfate drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| PAR PHARMACEUTICAL INC | neostigmine methylsulfate and glycopyrrolate | 42023-269 |
| >Company | >Ingredient | >NDC |
neostigmine methylsulfate drug variants not containing HYDROCHLORIC ACID
Excipient focus: NITROGEN
neostigmine methylsulfate drug variants containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| PAR PHARMACEUTICAL INC | neostigmine methylsulfate and glycopyrrolate | 42023-269 |
| >Company | >Ingredient | >NDC |
neostigmine methylsulfate drug variants not containing NITROGEN
Excipient focus: PHENOL
neostigmine methylsulfate drug variants containing PHENOL
neostigmine methylsulfate drug variants not containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | neostigmine methylsulfate | 0641-6240 |
| PAR PHARMACEUTICAL INC | neostigmine methylsulfate and glycopyrrolate | 42023-269 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE
neostigmine methylsulfate drug variants containing SODIUM ACETATE
neostigmine methylsulfate drug variants not containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| PAR PHARMACEUTICAL INC | neostigmine methylsulfate and glycopyrrolate | 42023-269 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
neostigmine methylsulfate drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| PAR PHARMACEUTICAL INC | neostigmine methylsulfate and glycopyrrolate | 42023-269 |
| >Company | >Ingredient | >NDC |
neostigmine methylsulfate drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
neostigmine methylsulfate drug variants containing SODIUM HYDROXIDE
neostigmine methylsulfate drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Indoco Remedies Limited | neostigmine methylsulfate | 14445-413 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
neostigmine methylsulfate drug variants containing WATER
neostigmine methylsulfate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Caplin Steriles Limited | neostigmine methylsulfate | 65145-111 |
| Somerset Therapeutics LLC | neostigmine methylsulfate | 70069-805 |
| Medical Purchasing Solutions LLC | neostigmine methylsulfate | 71872-7271 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
